Annual EBIT
-$110.78 M
-$24.01 M-27.68%
December 31, 2023
Summary
- As of February 8, 2025, ORIC annual earnings before interest & taxes is -$110.78 million, with the most recent change of -$24.01 million (-27.68%) on December 31, 2023.
- During the last 3 years, ORIC annual EBIT has fallen by -$61.44 million (-124.51%).
- ORIC annual EBIT is now -395.19% below its all-time high of -$22.37 million, reached on December 31, 2018.
Performance
ORIC EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$38.32 M
-$2.30 M-6.39%
September 30, 2024
Summary
- As of February 8, 2025, ORIC quarterly earnings before interest & taxes is -$38.32 million, with the most recent change of -$2.30 million (-6.39%) on September 30, 2024.
- Over the past year, ORIC quarterly EBIT has dropped by -$9.64 million (-33.60%).
- ORIC quarterly EBIT is now -503.81% below its all-time high of -$6.35 million, reached on March 1, 2019.
Performance
ORIC Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$134.75 M
-$9.64 M-7.70%
September 30, 2024
Summary
- As of February 8, 2025, ORIC TTM earnings before interest & taxes is -$134.75 million, with the most recent change of -$9.64 million (-7.70%) on September 30, 2024.
- Over the past year, ORIC TTM EBIT has dropped by -$33.28 million (-32.80%).
- ORIC TTM EBIT is now -2023.43% below its all-time high of -$6.35 million, reached on March 1, 2019.
Performance
ORIC TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ORIC EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -27.7% | -33.6% | -32.8% |
| 3 y3 years | -124.5% | -33.6% | -32.8% |
| 5 y5 years | -395.2% | -33.6% | -32.8% |
ORIC EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -40.5% | at low | -85.2% | at low | -70.8% | at low |
| 5 y | 5-year | -287.8% | at low | -336.9% | at low | -371.7% | at low |
| alltime | all time | -395.2% | at low | -503.8% | at low | -2023.4% | at low |
ORIC Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$38.32 M(+6.4%) | -$134.75 M(+7.7%) |
| Jun 2024 | - | -$36.02 M(+24.2%) | -$125.12 M(+9.7%) |
| Mar 2024 | - | -$28.99 M(-7.8%) | -$114.09 M(+3.0%) |
| Dec 2023 | -$110.78 M(+27.7%) | -$31.43 M(+9.6%) | -$110.78 M(+9.2%) |
| Sep 2023 | - | -$28.68 M(+14.8%) | -$101.47 M(+8.5%) |
| Jun 2023 | - | -$24.99 M(-2.7%) | -$93.48 M(+4.8%) |
| Mar 2023 | - | -$25.68 M(+16.1%) | -$89.19 M(+2.8%) |
| Dec 2022 | -$86.77 M(+10.0%) | -$22.12 M(+6.9%) | -$86.77 M(-0.8%) |
| Sep 2022 | - | -$20.69 M(-0.0%) | -$87.45 M(+2.6%) |
| Jun 2022 | - | -$20.70 M(-11.0%) | -$85.22 M(-0.4%) |
| Mar 2022 | - | -$23.26 M(+2.0%) | -$85.58 M(+8.5%) |
| Dec 2021 | -$78.87 M | -$22.80 M(+23.6%) | -$78.87 M(+8.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$18.46 M(-12.4%) | -$72.48 M(+8.7%) |
| Jun 2021 | - | -$21.06 M(+27.2%) | -$66.65 M(+17.5%) |
| Mar 2021 | - | -$16.55 M(+0.9%) | -$56.72 M(+14.9%) |
| Dec 2020 | -$49.34 M(+72.7%) | -$16.41 M(+29.9%) | -$49.34 M(+18.3%) |
| Sep 2020 | - | -$12.63 M(+13.6%) | -$41.70 M(+15.3%) |
| Jun 2020 | - | -$11.12 M(+21.2%) | -$36.17 M(+15.2%) |
| Mar 2020 | - | -$9.18 M(+4.7%) | -$31.40 M(+9.9%) |
| Dec 2019 | -$28.57 M(+27.7%) | -$8.77 M(+23.6%) | -$28.57 M(+44.3%) |
| Sep 2019 | - | -$7.10 M(+11.7%) | -$19.80 M(+55.9%) |
| Jun 2019 | - | -$6.36 M(+0.1%) | -$12.70 M(+100.1%) |
| Mar 2019 | - | -$6.35 M | -$6.35 M |
| Dec 2018 | -$22.37 M | - | - |
FAQ
- What is ORIC Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for ORIC Pharmaceuticals?
- What is ORIC Pharmaceuticals annual EBIT year-on-year change?
- What is ORIC Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for ORIC Pharmaceuticals?
- What is ORIC Pharmaceuticals quarterly EBIT year-on-year change?
- What is ORIC Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for ORIC Pharmaceuticals?
- What is ORIC Pharmaceuticals TTM EBIT year-on-year change?
What is ORIC Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of ORIC is -$110.78 M
What is the all time high annual EBIT for ORIC Pharmaceuticals?
ORIC Pharmaceuticals all-time high annual earnings before interest & taxes is -$22.37 M
What is ORIC Pharmaceuticals annual EBIT year-on-year change?
Over the past year, ORIC annual earnings before interest & taxes has changed by -$24.01 M (-27.68%)
What is ORIC Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of ORIC is -$38.32 M
What is the all time high quarterly EBIT for ORIC Pharmaceuticals?
ORIC Pharmaceuticals all-time high quarterly earnings before interest & taxes is -$6.35 M
What is ORIC Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, ORIC quarterly earnings before interest & taxes has changed by -$9.64 M (-33.60%)
What is ORIC Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of ORIC is -$134.75 M
What is the all time high TTM EBIT for ORIC Pharmaceuticals?
ORIC Pharmaceuticals all-time high TTM earnings before interest & taxes is -$6.35 M
What is ORIC Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, ORIC TTM earnings before interest & taxes has changed by -$33.28 M (-32.80%)